Global Veterinary Dermatology Drugs Market Size and Forecast 2024-2033|Elanco Animal Health Inc., Merk & Co. Inc., Zoetis Inc., Vetoquinol SA, Ceva Santé Animale

The fungal disease lichen in a cat under the coat is a dry crust of sores with hair loss. Veterinarian's hands in gloves, wound close-up

The Veterinary Dermatology Drugs Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Veterinary Dermatology Drugs Market:

https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report

According to The Business Research Company’s Veterinary Dermatology Drugs Global Market Report 2024, The veterinary dermatology drugs market size has grown rapidly in recent years. It will grow from $7.75 billion in 2023 to $8.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to prevalence of dermatological conditions, increased veterinary spending, changing environmental factors, companion animal healthcare awareness, regulatory approvals, zoonotic disease awareness.

The veterinary dermatology drugs market size is expected to see rapid growth in the next few years. It will grow to $13.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to growing pet insurance adoption, rising incidence of allergies, globalization of pet products, holistic pet care approach, companion animal population growth, consumer education.. Major trends in the forecast period include advancements in veterinary dermatology research, focus on allergy management, demand for topical treatments, nutraceuticals and dermatological health, telemedicine in veterinary dermatology, customized and personalized therapies, pet insurance and healthcare spending.

The increase number of pet owners is expected to propel the growth of the veterinary dermatology drugs market going forward. Pet owners are individuals who own or adopt a pet animal. Pet owners take care of their pets and their health, thus providing necessary health facilities to the pets, which increases the demand for veterinary drugs. For instance, in 2021, according to a national poll by the American Society for the Prevention of Cruelty to Animals (ASPCA), a US-based non-profit organization working to prevent animal cruelty, out of all the respondents, one in five households had a cat or dog from the beginning of the COVID-19 crisis, which accounted for 23 million households. 90% of dogs and 85% of cats were still in their adopted homes, and the households were not considering abandoning them again. Therefore, the increasing number of pet owners is driving the veterinary dermatology drugs market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8025&type=smp

The veterinary dermatology drugs market covered in this report is segmented –

1) By Product Type: Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs

2) By Animal Type: Companion Animal, Livestock Animal

3) By Drug Indication: Parasitic Infections, Allergic Infections, Other Indications

4) By Route of Administration: Topical, Injectable, Oral

5) By Distribution Channel: Retail, Hospital Pharmacies, Online

Major companies operating in the veterinary dermatology drugs market are developing new enzyme-based healthcare solutions to sustain their position in the market. For instance, in October 2022, Pet King Brands Inc., a US-based pet care company unveiled an expansion to its ZYMOX Enzymatic Dermatology product line with three new offerings designed specifically for cats and kittens. These additions, featuring feline-centric packaging and the Seal of Endorsement from TICA (The International Cat Association), aim to address ear and skin conditions in felines without the use of antibiotics or harsh ingredients. The ZYMOX for Cats and Kittens range includes Enzymatic Ear Solution with 0.5% Hydrocortisone, Enzymatic Ear Cleanser, and Enzymatic Topical Cream with 0.5% Hydrocortisone. The products leverage the patented LP3 Enzyme System, providing effective solutions for common feline conditions such as ear infections, irritated skin, hot spots, ringworm, and acne.

The veterinary dermatology drugs market report table of contents includes:

1. Executive Summary

2. Veterinary Dermatology Drugs Market Characteristics

3. Veterinary Dermatology Drugs Market Trends And Strategies

4. Veterinary Dermatology Drugs Market – Macro Economic Scenario

5. Global Veterinary Dermatology Drugs Market Size and Growth

26. South America Veterinary Dermatology Drugs Market

27. Brazil Veterinary Dermatology Drugs Market

28. Middle East Veterinary Dermatology Drugs Market

29. Africa Veterinary Dermatology Drugs Market

30. Veterinary Dermatology Drugs Market Competitive Landscape And Company Profiles

Top Major Players: